Hassen Mohammed
Adelaide Medical School
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Dr. Hassen Mohammed, an Early Career Researcher at the Vaccinology and Immunology Research Trials Unit (VIRTU), earned his Ph.D. from the University of Adelaide in 2021. His research primarily centers around the epidemiology and burden of vaccine-preventable diseases, vaccine coverage, safety, and effectiveness. Since beginning his Ph.D. in 2017, he has published 19 peer-reviewed studies, including nine first-author publications, with a field-weighted citation impact of 3.27 (2018-2024). He has also contributed to commissioned evaluations of vaccine programs, such as South Australia's School Immunisation Programs , the COVID-19 vaccine roll-out in SA (2022), and the distribution of the 2020 SA Influenza vaccine. Additionally, he has been involved in drafting the Australian Technical Advisory Group on Immunisation (ATAGI) advice for pre-Pharmaceutical Benefits Advisory Committee (PBAC) submissions (2021-2022).
Hassen is an early-career researcher at Vaccinology and Immunology Research Trials Unit (VIRTU). He completed his honours degree with a first class and awarded his PhD in 2021 from the University of Adelaide. His research interest include broadly in areas of vaccine preventable diseases, vaccine coverage, safety and effectiveness.
-
Language Competencies
Language Competency Amharic Can read, write, speak, understand spoken and peer review English Can read, write, speak, understand spoken and peer review -
Education
Date Institution name Country Title 2017 - 2021 University of Adelaide, Adelaide Australia Ph.D in Medicine 2016 - 2016 University of Adelaide, Adelaide Australia Bachelor of Health Sciences - First Class Honours 2012 - 2015 University of Adelaide, Adelaide Australia Bachelor of Health Science -
Research Interests
-
Journals
Year Citation 2025 Mohammed, H., Riley, K., Clarke, M., Walker, M. S., & Marshall, H. S. (2025). Provider Determinants of Maternal Influenza and Pertussis Vaccination Uptake in South Australia in a Tertiary Healthcare Setting. Journal of Clinical Medicine, 14(3), 14 pages.
2024 McMillan, M., Mohammed, H., Bednarz, J., Leong, L. E. X., Lawrence, A., Sullivan, T. R., . . . Marshall, H. S. (2024). Longitudinal study of meningococcal carriage in adolescents and young adults in South Australia 2017-2020. Journal of Infection, 88(2), 149-157.
Scopus1 Europe PMC12024 Naghavi, M., Ong, K. L., Aali, A., Ababneh, H. S., Abate, Y. H., Abbafati, C., . . . Murray, C. J. L. (2024). Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 403(10440), 2100-2132.
Scopus362 Europe PMC2342024 Mohammed, H., Peut, C., McMillan, M., Wang, B., Sullivan, T. R., & Marshall, H. S. (2024). The Role of Schools in Meningococcal Carriage among Adolescents and Young Adults in South Australia. Pediatric Infectious Disease Journal, 43(7), e249-e251.
2024 Wang, B., Mohammed, H., Andraweera, P., McMillan, M., & Marshall, H. (2024). Vaccine effectiveness and impact of meningococcal vaccines against gonococcal infections: A systematic review and meta-analysis. Journal of Infection, 89(3), 10 pages.
Scopus3 Europe PMC22023 Mohammed, H., Pham-Tran, D. D., Yeoh, Z. Y. M., Wang, B., McMillan, M., Andraweera, P. H., & Marshall, H. S. (2023). A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529). Vaccines, 11(2), 1-19.
Scopus26 WoS3 Europe PMC212023 Wang, B., Andraweera, P., Elliott, S., Mohammed, H., Lassi, Z., Twigger, A., . . . Marshall, H. (2023). Asymptomatic SARS-CoV-2 Infection by Age: A Global Systematic Review and Meta-analysis. The Pediatric Infectious Disease Journal, 42(3), 232-239.
Scopus28 WoS11 Europe PMC212023 McRae, J. E., McHugh, L., King, C., Beard, F. H., Blyth, C. C., Danchin, M. H., . . . Macartney, K. (2023). Influenza and pertussis vaccine coverage in pregnancy in Australia, 2016–2021. Medical Journal of Australia, 218(11), 528-541.
Scopus11 Europe PMC52023 Tuckerman, J., Riley, K., Straube, S., Mohammed, H., Danchin, M., & Marshall, H. S. (2023). Interventions for increasing the uptake of immunisations in healthcare workers: A systematic review. Vaccine, 41(38), 5499-5506.
2021 Mohammed, H., Roberts, C. T., Grzeskowiak, L. E., Giles, L. C., Verburg, P., Dekker, G., & Marshall, H. S. (2021). Safety of maternal pertussis vaccination on pregnancy and birth outcomes: a prospective cohort study. Vaccine, 39(2), 324-331.
Scopus10 WoS6 Europe PMC62021 Alene, K. A., Gelaw, Y. A., Fetene, D. M., Koye, D. N., Melaku, Y. A., Gesesew, H., . . . Kinfu, Y. (2021). COVID-19 in Ethiopia: a geospatial analysis of vulnerability to infection, case severity and death. BMJ Open, 11(2), e044606-1-e044606-11.
Scopus18 WoS14 Europe PMC142021 Gesesew, H. A., Koye, D. N., Fetene, D. M., Woldegiorgis, M., Kinfu, Y., Geleto, A. B., . . . Adane, A. A. (2021). Risk factors for COVID-19 infection, disease severity and related deaths in Africa: a systematic review. BMJ Open, 11(2), e044618-1-e044618-10.
Scopus49 WoS37 Europe PMC442021 Mohammed, H., McMillan, M., & Marshall, H. S. (2021). Social and behavioral predictors of two-doses 4CMenB vaccine series among adolescents enrolled in a cluster randomized controlled trial in Australia. Human Vaccines & Immunotherapeutics, 18(1), 1-9.
WoS12021 Mohammed, H., McMillan, M., Andraweera, P. H., Elliott, S. R., & Marshall, H. S. (2021). A rapid global review of strategies to improve influenza vaccination uptake in Australia.. Human vaccines & immunotherapeutics, 17(12), 1-13.
Scopus7 WoS2 Europe PMC42021 Tessema, G. A., Kinfu, Y., Dachew, B. A., Tesema, A. G., Assefa, Y., Alene, K. A., . . . Tesfay, F. H. (2021). The COVID-19 pandemic and healthcare systems in Africa: a scoping review of preparedness, impact and response. BMJ Global Health, 6(12), e007179-1-e007179-14.
Scopus147 WoS55 Europe PMC1142020 Mohammed, H., Roberts, C. T., Grzeskowiak, L. E., Giles, L., Leemaqz, S., Dalton, J., . . . Marshall, H. S. (2020). Psychosocial determinants of pertussis and influenza vaccine uptake in pregnant women: A prospective study.. Vaccine, 38(17), 3358-3368.
Scopus20 WoS16 Europe PMC102020 Deshpande, A., Miller-Petrie, M. K., Lindstedt, P. A., Baumann, M. M., Johnson, K. B., Blacker, B. F., . . . Behzadifar, M. (2020). Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17. The Lancet Global Health, 8(9), e1162-e1185.
Scopus106 WoS62 Europe PMC642020 Mohammed, H., Roberts, C. T., Grzeskowiak, L. E., Giles, L. C., Dekker, G. A., & Marshall, H. S. (2020). Safety and protective effects of maternal influenza vaccination on pregnancy and birth outcomes: A prospective cohort study. EClinicalMedicine, 26, 1-9.
Scopus17 WoS6 Europe PMC62019 Mohammed, H., McMillan, M., Roberts, C. T., & Marshall, H. S. (2019). A systematic review of interventions to improve uptake of pertussis vaccination in pregnancy.. PloS one, 14(3), 0214538.
Scopus33 WoS24 Europe PMC182018 Mohammed, H., Clarke, M., Koehler, A., Watson, M., & Marshall, H. (2018). Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia. PLoS ONE, 13(6), e0197867-1-e0197867-14.
Scopus61 WoS48 Europe PMC31 -
Report for External Bodies
Year Citation 2023 McMillan, M., Mohammed, H., Saunders, L., Clarke, M., & Marshall, H. (2023). School immunisation program review South Australia. 2022 McMillan, M., Mohammed, H., Wang, B., Saunders, L., Clarke, M., McDonough, J., & Marshall, H. (2022). Review of the COVID-19 vaccine program in South Australia. 2021 Elliott, S., Andraweera, P., McMillan, M., Evans, S., Wang, B., Mohammed, H., . . . Marshall, H. (2021). Review of 2020 Influenza vaccine distribution in South Australia.
Connect With Me
External Profiles
